| 1 |
|
Admedus Charts An Eclectic Path To A Global Future
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2015
|
|
|
|
| 2 |
|
All about value-olympus medical gets to feel the nice effect
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2015
|
|
|
|
| 3 |
|
ANGLE Targets A Rich CTC Niche In Liquid Biopsy
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 4 |
|
Arthroplasty physicians trade views if not blows at world congress
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2015
|
|
|
|
| 5 |
|
Atlas Genetics Ready To Play Its Part In The POC Workflow Revolution
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 6 |
|
Becton Dickinson Adds A Bigger Jewel To Its String Of Pearls
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2015
|
|
|
|
| 7 |
|
Boston Scientific Thinks Big In HF Provider Risk-Share Plan
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 8 |
|
Brexit Effect On UK Medtech: View From The US
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 9 |
|
BTG Deals Its Way Into Interventional Medicine
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 10 |
|
CardiNor Leads The Charge As Norway Gets Behind Life Sciences
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 11 |
|
Changing Mind-Set Spurring Robotics In Ortho Surgery
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2015
|
|
|
|
| 12 |
|
CVRx's Investment In HF And Wider Medtech Industry Set To Pay Off CVRx president and CEO Nadim Yared believes his company's second-generation chronic heart failure device could present a serious commercial challenge to the traditional major players in the field. Meantime, with 10 years under his belt as CEO, Yared is focused on building the company, rather than on exits
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 13 |
|
European IVD Companies See Worrying Trend In Market Access Barriers
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 14 |
|
Fujifilm Promises A Shake-Up Of Regenerative Medicines Market
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 15 |
|
GE healthcare pursues a license to build in life science innovation
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2014
|
|
|
|
| 16 |
|
Guided Therapy Systems Keeps Options Open On Tissue Regen Device GTS'CEO Michael Slayton describes the 22-year engineering journey that has led him and the company he founded to the cusp of market launch of a non-invasive tissue regeneration device for musculoskeletal injuries
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 17 |
|
Hitachi takes the fast track to a data-driven future
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2015
|
|
|
|
| 18 |
|
How To Restructure: Admedus Opts For A Restart
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 19 |
|
Intuitive's da vinci: will familiarity breed success?
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2015
|
|
|
|
| 20 |
|
Israel's Medtech Looks To A Future Beyond Start-Ups
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
